IL-8 predicts pediatric oncology patients with febrile neutropenia at low risk for bacteremia

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 3, 2013, Pages 206-211

  Cost, Carrye R ^a   Stegner, Martha M ^a   Leonard, David ^b   Leavey, Patrick ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Febrile neutropenia; IL 8; Pediatric oncology; Risk prediction

Indexed keywords

C REACTIVE PROTEIN; CEFTRIAXONE; CYTARABINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PIPERACILLIN PLUS TAZOBACTAM; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ARTICLE; BACTEREMIA; CANCER PATIENT; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CHILDHOOD MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; FALSE NEGATIVE RESULT; FEBRILE NEUTROPENIA; FEMALE; FLUID RESUSCITATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMODYNAMICS; HUMAN; HYPOTENSION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; PNEUMONIA; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; UROSEPSIS; VIRAL RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; BACTEREMIA; BACTERIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTERLEUKIN-8; MALE; NEOPLASMS; NEUTROPENIA; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84876114236     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318281e653     Document Type: Article

References (31)

1. Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis. 2004;39(suppl 1):S32-S37.
2. Picazo JJ. Management of the febrile neutropenic patient: a consensus conference. Clin Infect Dis. 2004;39(suppl 1):S1-S6.
3. Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins xv, 1692 pp; 2002.
4. Hartel C, Deuster M, Lehrnbecher T, et al. Current approaches for risk stratification of infectious complications in pediatric oncology. Pediatr Blood Cancer. 2007;49: 767-773.
5. Teuffel O, Amir E, Alibhai SM, et al. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer. Pediatrics. 2011;127:e279-e286.
6. Elting LS, Lu C, Escalante CP, et al. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol. 2008;26: 606-611.
7. Sung L, Feldman BM, Schwamborn G, et al. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences. J Clin Oncol. 2004;22: 3922-3929.
8. Macher E, Dubos F, Garnier N, et al. Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia. Pediatr Blood Cancer. 2010;55: 662-667.
9. Phillips B, Wade R, Stewart LA, et al. Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people. Eur J Cancer. 2010;46: 2950-2964.
10. Lehrnbecher T, Venzon D, de Haas M, et al. Assessment of measuring circulating levels of interleukin-6, interleukin-8, Creactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis. 1999;29: 414-419.
11. de Bont ES, Vellenga E, Swaanenburg JC, et al. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol. 1999;107: 375-380.
12. Hodge G, Osborn M, Hodge S, et al. Rapid simultaneous measurement of multiple cytokines in childhood oncology patients with febrile neutropenia: increased interleukin (IL)-8 or IL-5 correlates with culture-positive infection. Br J Haematol. 2006;132: 247-248.
13. Oude Nijhuis C, Kamps WA, Daenen SM, et al. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol. 2005;23: 7437-7444.
14. Kern WV, Heiss M, Steinbach G. Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy. Clin Infect Dis. 2001;32: 832-835.
15. Urbonas V, Eidukaite A, Tamuliene I. The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer. J Pediatr Hematol Oncol. 2012;34: 122-127.
16. Badurdeen S, Hodge G, Osborn M, et al. Elevated serum cytokine levels using cytometric bead arrays predict culturepositive infections in childhood oncology patients with febrile neutropenia. J Pediatr Hematol Oncol. 2012;34:e36-e38.
17. Christensen MS, Nielsen LP, Hasle H. Few but severe viral infections in children with cancer: a prospective RT-PCR and PCR-based 12-month study. Pediatr Blood Cancer. 2005;45: 945-951.
18. Koskenvuo M, Mottonen M, Rahiala J, et al. Respiratory viral infections in children with leukemia. Pediatr Infect Dis J. 2008;27: 974-980.
19. Lindblom A, Bhadri V, Soderhall S, et al. Respiratory viruses, a common microbiological finding in neutropenic children with fever. J Clin Virol. 2010;47: 234-237.
20. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6: 2-8.
21. Werba BE, Hobbie W, Kazak AE, et al. Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2). Pediatr Blood Cancer. 2007;48: 673-677.
22. Ammann RA, Bodmer N, Hirt A, et al. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol . 2010;28: 2008-2014.
23. Rackoff WR, Gonin R, Robinson C, et al. Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol. 1996;14: 919-924.
24. Santolaya ME, Alvarez AM, Aviles CL, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis. 2002;35: 678-683.
25. Miedema KG, de Bont ES, Elferink RF, et al. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Support Care Cancer. 2011;19: 1593-1600.
26. Diepold M, Noellke P, Duffner U, et al. Performance of interleukin-6 and interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC Infect Dis. 2008;8: 28.
27. Klaassen RJ, Goodman TR, Pham B, et al. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18: 1012-1019.
28. Baorto EP, Aquino VM, Mullen CA, et al. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001;92: 909-913.
29. van Elden LJ, van Kraaij MG, Nijhuis M, et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin Infect Dis. 2002;34: 177-183.
30. Miller MR, Griswold M, Harris JM II, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics. 2010;125: 206-213.
31. Lash GE, Scaife PJ, Innes BA, et al. Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight and FAST Quant. J Immunol Methods. 2006;309: 205-208.